|
Cabergoline (125 mg)
|
|
|
Caffeine (200 mg)
|
|
|
Caffeine Melting Point Standard (1 g) (Approximately 236 degrees)
|
|
|
Caftaric Acid (20 mg)
|
|
|
Calcifediol (75 mg)
|
|
|
Calcipotriene (200 mg)
|
|
|
Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol)
|
|
|
Calcitonin Salmon (40 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Calcitonin Salmon Related Compound A (10 mg) (N-acetyl-Cys1-calcitonin salmon) (COLD SHIPMENT REQUIRED)
|
|
|
カルシトニン サケ関連化合物 B (calcitonin salmon-glycine)
販売終了
|
|
|
Calcitriol (10 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Calcitriol Solution (5 mL) (COLD SHIPMENT REQUIRED)
|
|
|
Calcium Acetate (500 mg)
|
|
|
Calcium Ascorbate (200 mg)
|
|
|
Calcium Benzoate (200 mg)
|
|
|
Calcium Carbonate (1 g)
|
|
|
Calcium Citrate Malate (200 mg)
|
|
|
Calcium Chloride (1 g)
|
|
|
Calcium Gluceptate (200 mg)
|
|
|
Calcium Gluconate Anhydrous (200 mg)
|
|
|
Calcium Gluconate Monohydrate (200 mg) (Calcium D-Gluconate Monohydrate)
|
|
|
水酸化カルシウム (AS)
販売終了
|
|
|
Calcium (-)-Hydroxycitrate (150 mg)
|
|
|
Calcium Lactate (1 g)
|
|
|
Calcium Lactobionate (200 mg)
|
|
|
Calcium Levulinate (1 g) (AS)
|
|
|
Calcium Pantothenate (300 mg) (Vitamin B5)
|
|
|
Tribasic Calcium Phosphate (1 g) (AS)
|
|
|
Calcium Saccharate (200 mg)
|
|
|
Calcium Succinate (200 mg)
|
|
|
Calcium Sulfate (AS)
販売終了
|
|
|
Calycosin (50 mg) (7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one)
|
|
|
Calycosin 7-O-beta-D-Glucopyranoside (50 mg) (3-(3-Hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside)
|
|
|
Camphor (1 g)
|
|
|
Candesartan Cilexetil (100 mg)
|
|
|
Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate)
|
|
|
Candesartan Cilexetil Related Compound B (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate)
|
|
|
Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate)
|
|
|
Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate)
|
|
|
Candesartan Cilexetil Related Compound G (10 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid)
|
|
|
Canola Oil (1 g)
|
|
|
Capecitabine (200 mg)
|
|
|
Capecitabine Related Compound A (15 mg) (5'-deoxy-5-fluorocytidine)
|
|
|
Capecitabine Related Compound B (20 mg) (5'-deoxy-5-fluorouridine)
|
|
|
Capecitabine Related Compound C (10 mg) (2',3'-O-carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine) (COLD SHIPMENT REQUIRED)
|
|
|
Capreomycin Sulfate (250 mg)
|
|
|
Capric Alcohol (5 x 30 mg)
|
|
|
Caprolactam (1 g)
|
|
|
Caprylic Acid (300 mg)
|
|
|
Capsaicin (100 mg)
|
|
|
Captopril (200 mg)
|
|
|
Captopril Disulfide (100 mg)
|
|
|
カプリロカプロイルポリオキシルグリセリド
|
|
|
Carbachol (200 mg)
|
|
|
Carbamazepine (100 mg)
|
|
|
Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine)
|
|
|
Carbamazepine Related Compound B (50 mg) (5H-Dibenz[b,f]azepine)
|
|
|
カルベニシリンインダニルナトリウム
販売終了
|
|
|
Carbidopa (400 mg)
|
|
|
Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa)
|
|
|
Carbinoxamine Maleate (200 mg)
|
|
|
Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone)
|
|
|
Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol)
|
|
|
Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate)
|
|
|
Carboplatin (100 mg)
|
|
|
Carboprost Tromethamine (30 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid)
|
|
|
Carboxymethylcellulose Calcium (1.5 g) (AS)
|
|
|
Carboxymethylcellulose Sodium (1.5 g)
|
|
|
D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid)
|
|
|
Carglumic Acid (200 mg)
|
|
|
Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate)
|
|
|
Carmellose (500 mg)
|
|
|
Carvedilol (200 mg)
|
|
|
Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
|
|
|
Carvedilol Related Compound B (15 mg) (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
|
|
|
Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol)
|
|
|
Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmethoxy)-9H-carbazole)
|
|
|
Carvedilol Related Compound E (15 mg) (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
|
|
|
Carvedilol System Suitability Mixture (25 mg) (carvedilol spiked with carvedilol related compound F)
|
|
|
Carprofen (200 mg)
|
|
|
Carprofen Related Compound A (50 mg) (Carbazole)
|
|
|
Carmustine Related Compound A (25 mg) (1,3-bis(2-chloroethyl)urea)
|
|
|
Carnosic acid (20 mg)
|
|
|
Carteolol Hydrochloride (200 mg)
|
|
|
Casticin (25 mg)
|
|
|
(+)-Catechin (25 mg)
|
|
|
Castor Oil (3 x 100 mg)
|
|
|
Hydrogenated Castor Oil (250 mg) (Mixture containing about 83% triglyceride of 12-hydroxystearic acid)
|
|
|
Powdered Cat's Claw Extract (1 g)
|
|
|
Cefaclor (400 mg)
|
|
|
Cefaclor Delta-3 Isomer (15 mg)
|
|
|
Cefadroxil System Suitability Mixture (25 mg) (Mixture of cefadroxil and O-ethoxycarbonyl cefadroxil)
|
|
|
Cefadroxil (200 mg)
|
|
|
Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
|
|
|
Cefadroxil Related Compound D (25 mg) ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
|
|
|
Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
|
|
|
セファマンドールナファート
販売終了
|
|
|
Cefdinir Related Compound B (10 mg) ((6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid)
|
|
|
Cefazolin (200 mg)
|
|
|
Cefdinir (300 mg)
|
|
|
Cefdinir Related Compound A (10 mg) ((2R)-2-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid)
|
|
|
Cefepime Hydrochloride (500 mg)
|
|
|
Cefixime (500 mg)
|
|
|
Cefepime Related Compound D (20 mg) ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid)
|
|
|
Cefepime Related Compound E (20 mg) (1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride)
|
|
|
Cefoperazone Dihydrate (200 mg)
|
|
|
Cefetamet (15 mg)
|
|
|
Cefonicid Sodium (1 g) (COLD SHIPMENT REQUIRED)
|
|
|
Cefmetazole (200 mg)
|
|
|
Ceforanide (200 mg)
|
|
|
Cefotaxime Sodium (500 mg)
|
|
|
Cefotaxime Related Compound E (15 mg) ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
|
|
|
Cefotetan (500 mg)
|
|
|
Cefprozil Related Compound D (30 mg) ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
|
|
|
Cefprozil L-Epimer (30 mg) ((6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
|
|
|
セホチアム塩酸塩
販売終了
|
|
|
Cefpodoxime Proxetil (350 mg)
|
|
|
Cefprozil (E)-Isomer (50 mg)
|
|
|
Cefprozil (Z)-Isomer (200 mg)
|
|
|
Cefprozil (200 mg)
|
|
|
Ceftiofur Hydrochloride (100 mg)
|
|
|
Ceftiofur System Suitability Mixture (50 mg) (A mixture containing ceftiofur, ceftiofur delta-3 isomer and ceftiofur E-isomer)
|
|
|
Cefoxitin (500 mg)
|
|
|
Ceftazidime Delta-3-Isomer (15 mg)
|
|
|
Ceftazidime Pentahydrate (300 mg)
|
|
|
Ceftiofur Sodium Trihydrate (100 mg)
|
|
|
Ceftizoxime (350 mg)
|
|
|
Ceftriaxone Sodium (350 mg)
|
|
|
Ceftriaxone Sodium E-Isomer (25 mg)
|
|
|
セフロキシムナトリウム
|
|
|
Cefuroxime Axetil (350 mg)
|
|
|
Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)
|
|
|
Cefuroxime Axetil E-isomers (15 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)
|
|
|
Cellulose Acetate (125 mg)
|
|
|
Cellaburate (350 mg) (Cellulose Acetate Butyrate)
|
|
|
Cellacefate (125 mg) (Cellulose Acetate Phthalate)
|
|
|
Microcrystalline Cellulose (1 g)
|
|
|
Celecoxib (200 mg)
|
|
|
Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
|
|
|
Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
|
|
|
Celecoxib Related Compound C (25 mg) (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
|
|
|
Celecoxib Related Compound D (25 mg) ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide)
|
|
|
Cephalexin (400 mg)
|
|
|
Cephalexin Related Compound D (25 mg) (3-Hydroxy-4-methylthiophen-2(5H)-one)
|
|
|
Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
|
|
|
Cephalothin Sodium (200 mg)
|
|
|
Cephapirin Benzathine (100 mg)
|
|
|
Cephapirin Sodium (500 mg)
|
|
|
Cephradine (300 mg)
|
|
|
Cetirizine Hydrochloride (250 mg)
|
|
|
Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate)
|
|
|
Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride)
|
|
|
Cetirizine Related Compound C (25 mg) (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide)
|
|
|
Cetirizine Related Compound G (50 mg) (2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol dihydrochloride)
|
|
|
Cetrimonium Bromide (1 g)
|
|
|
Cetyl Alcohol (100 mg)
|
|
|
Cetyl Palmitate (50 mg)
|
|
|
Cetylpyridinium Chloride (500 mg)
|
|
|
Chicoric Acid (20 mg)
|
|
|
Powdered Chinese Salvia Extract (1 g)
|
|
|
Chitosan (500 mg)
|
|
|
Chlorambucil System Suitability Mixture (25 mg) (A mixture containing 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid and a small amount of 4-[m-[Bis(2-chloroethyl)amino]phenyl]butyric acid)
|
|
|
Chloramphenicol (200 mg)
|
|
|
Chloramphenicol Palmitate (200 mg)
|
|
|
Chloramphenicol Palmitate Nonpolymorph A (200 mg)
|
|
|
Chloramphenicol Palmitate Polymorph A (100 mg)
|
|
|
Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide)
|
|
|
Chlorhexidine (200 mg)
|
|
|
Chlorhexidine System Suitability Mixture (50 mg)
|
|
|
Chlorhexidine Acetate (200 mg)
|
|
|
P-Chloroaniline (200 mg)
|
|
|
3-Chlorobenzoic Acid (25 mg)
|
|
|
Chlorobenzhydryl Piperazine (75 mg)
|
|
|
4-Chlorobenzophenone (30 mg) (4-Chlorobenzophenone)
|
|
|
Chlorobutanol (200 mg)
|
|
|
Chlorogenic Acid (50 mg)
|
|
|
beta-Chlorogenin (20 mg)
|
|
|
Chloromethyl Isopropyl Carbonate (100 mg)
|
|
|
Chlorophyll A (15 mg)
|
|
|
Chloroprocaine Hydrochloride (200 mg)
|
|
|
Chloropropyl Vanillin (25 mg) (4-(3-Chloropropoxy)-3-methoxybenzaldehyde)
|
|
|
Chloroquine Phosphate (200 mg)
|
|
|
Chloroquine Related Compound A (15 mg) (4,7-dichloroquinoline)
|
|
|
Chloroquine Related Compound D (15 mg) (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline)
|
|
|
Chloroquine Related Compound E (10 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
|
|
|
Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)
|
|
|
Chlorthalidone Related Compound A (10 mg) (4'-Chloro-3'-sulfamoyl-2-benzophenone Carboxylic Acid)
|
|
|
Chlorothiazide (200 mg)
|
|
|
Chloroxylenol (125 mg)
|
|
|
Chloroxylenol Related Compound A (25 mg) (2-chloro-3,5-dimethylphenol)
|
|
|
Chlorpheniramine Maleate (125 mg)
|
|
|
Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amine)
|
|
|
Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate)
|
|
|
Chlorpromazine Hydrochloride (200 mg)
|
|
|
Chlorpropamide (200 mg)
|
|
|
Chlortetracycline Hydrochloride (200 mg)
|
|
|
Chlorthalidone (200 mg)
|
|
|
Chlorzoxazone (350 mg)
|
|
|
Chlorzoxazone Related Compound A (50 mg) (2-Amino-4-chlorophenol)
|
|
|
Cholecalciferol (30 mg/ampule; 5 ampules) (Vitamin D3)
|
|
|
Cholestanol (200 mg)
|
|
|
Cholesterol (125 mg)
|
|
|
Cholesteryl Caprylate (200 mg)
|
|
|
Cholestyramine Resin (500 mg)
|
|
|
Cholic Acid (200 mg)
|
|
|
Choline Bitartrate (200 mg)
|
|
|
Choline Chloride (500 mg)
|
|
|
Choline Fenofibrate (50 mg) (2-Hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate)
|
|
|
Chondroitin Sulfate Sodium (300 mg)
|
|
|
Chromium Picolinate (100 mg)
|
|
|
L-Citrulline (200 mg)
|
|
|
Cidofovir (100 mg)
|
|
|
Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate)
|
|
|
Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine)
|
|
|
Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride)
|
|
|
Cinnamaldehyde (100 mg)
|
|
|
Cinnamomum Cassia Twig Powder (5 g)
|
|
|
Cinacalcet Related Compound C (50 mg) ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
|
|
|
Cinnamic Acid (100 mg)
|
|
|
Cinacalcet Related Compound D (50 mg) ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
|
|
|
Cinacalcet Hydrochloride (250 mg)
|
|
|
Chymotrypsin (300 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Ciclopirox (50 mg)
|
|
|
Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid)
|
|
|
Ciclopirox Olamine (125 mg)
|
|
|
Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone)
|
|
|
Cilastatin Ammonium Salt (100 mg)
|
|
|
Cimetidine (200 mg)
|
|
|
Cimetidine Hydrochloride (200 mg)
|
|
|
Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-methylpyridin-2(1H)-one)
|
|
|
Cisatracurium Besylate (350 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Cisapride (200 mg)
|
|
|
Cisatracurium Besylate System Suitability Mixture (20 mg)
|
|
|
R-Citalopram Oxalate (10 mg) ((R)-1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate)
|
|
|
Cilostazol (200 mg)
|
|
|
Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one)
|
|
|
Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
|
|
|
Cilostazol Related Compound C (50 mg) (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
|
|
|
Citalopram Related Compound G (25 mg) (3-[5-Chloro-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
|
|
|
Cladribine (200 mg)
|
|
|
Cladribine Related Compound A (20 mg) (2-methoxy-2'-deoxyadenosine)
|
|
|
Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide)
|
|
|
Citalopram Hydrobromide (200 mg)
|
|
|
Citalopram Related Compound A (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
|
|
|
Citalopram Related Compound B (25 mg) (1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate)
|
|
|
Citalopram Related Compound C (25 mg) (3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate)
|
|
|
Citalopram Related Compound D (15 mg) (1-(4-Fluorophenyl)-1-(3-methylaminopropyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride)
|
|
|
Citalopram Related Compound E (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride)
|
|
|
Citalopram Related Compound F (200 mg) (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride)
|
|
|
Citicoline Sodium (2 x 350 mg)
|
|
|
Ciprofloxacin (200 mg)
|
|
|
Ciprofloxacin Ethylenediamine Analog (25 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)amino]-3-quinolinecarboxylic acid hydrochloride)
|
|
|
Ciprofloxacin Hydrochloride (400 mg)
|
|
|
Ciprofloxacin Related Compound A (25 mg) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt)
|
|
|
Cisplatin (100 mg)
|
|
|
Citric Acid (200 mg)
|
|
|
Clarithromycin (100 mg)
|
|
|
Clarithromycin Related Compound A (25 mg) (6,11-di-O-methylerythromycin A)
|
|
|
Clarithromycin Identity (10 mg)
|
|
|
Clavam-2-carboxylate Potassium (2 mg)
|
|
|
Clavulanate Lithium (200 mg)
|
|
|
Ciprofloxacin Formamide (25 mg)
|
|
|
Clemastine Fumarate (250 mg)
|
|
|
Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin)
|
|
|
Clarithromycin Impurity H (10 mg) (3-N-Demethyl-3-N-formyl-6-O-methylerythromycin A)
|
|
|
Clarithromycin Impurity R (10 mg) (3-N-Demethylerythromycin A)
|
|
|
Clenbuterol Hydrochloride (100 mg)
|
|
|
Clenbuterol Related Compound B (10 mg) (1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone hydrochloride)
|
|
|
Clidinium Bromide (500 mg)
|
|
|
Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methylquinuclindinium Bromide)
|
|
|
Climbazole (400 mg)
|
|
|
Clindamycin Hydrochloride (200 mg)
|
|
|
Clindamycin Palmitate Hydrochloride (500 mg)
|
|
|
Clindamycin Phosphate (250 mg)
|
|
|
Clindamycin Phosphate System Suitability (Clindamycin phosphate containing 7-Epiclindamycin phosphate) (2.2 mg)
|
|
|
Clioquinol (500 mg)
|
|
|
Clobetasol Propionate (200 mg)
|
|
|
Clobetasol Propionate Related Compound A (50 mg) (9alpha-Fluoro-11Beta-hydroxy-16Beta-methyl 3-oxo-androsta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one])
|
|
|
Clocortolone Pivalate (200 mg)
|
|
|
Clofazimine (200 mg)
|
|
|
Clofazimine Related Compound B (25 mg) (5-(4-Chlorophenyl)-3-(isopropylimino)-N-phenyl-3,5-dihydrophenazin-2-amine)
|
|
|
クロフィブラート
販売終了
|
|
|
Clomiphene Citrate (500 mg)
|
|
|
Clomiphene Related Compound A (25 mg) ((E,Z)-2-[4-(1,2-Diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride)
|
|
|
Clomipramine Hydrochloride (200 mg)
|
|
|
Clomipramine Related Compound A (25 mg) (N1-[3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N1,N3,N3-trimethylpropane-1,3-diamine dihydrochloride)
|
|
|
Clomipramine Related Compound C (15 mg) (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
|
|
|
Clomipramine Related Compound D (15 mg) (3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride)
|
|
|
Clomipramine Related Compound F (15 mg) (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)
|
|
|
Clonazepam Related Compound A (25 mg) (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
|
|
|
Clonazepam Related Compound B (25 mg) (2-Amino-2'-chloro-5-nitrobenzophenone)
|
|
|
Clonazepam Related Compound C (25 mg) (2-bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide)
|
|
|
Clonidine (200 mg)
|
|
|
Clonidine Hydrochloride (200 mg)
|
|
|
Clonidine Related Compound A (25 mg) (1-Acetyl-2-(2,6-dichlorophenylimino)-imidazolidine)
|
|
|
Clonidine Related Compound B (25 mg) (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
|
|
|
Clopidogrel Bisulfate (125 mg)
|
|
|
Clopidogrel Related Compound A (20 mg) ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
|
|
|
Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride)
|
|
|
Clopidogrel Related Compound C (20 mg) (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
|
|
|
Cloprostenol Sodium (400 mg)
|
|
|
クロルスロン
|
|
|
Clotrimazole (200 mg)
|
|
|
Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)diphenylmethanol)
|
|
|
Cloxacillin Benzathine (200 mg)
|
|
|
クロキサシリンナトリウム
|
|
|
Clozapine (100 mg)
|
|
|
Clozapine Resolution Mixture (30 mg)
|
|
|
Cobamamide (3 x 100 mg) (5,6-Dimethylbenzimidazolyl-Co-5'-deoxyadenosylcobamide)
|
|
|
Cloxacillin Related Compound D (15 mg) (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)
|
|
|
Cod Liver Oil (1 g)
|
|
|
Coffee Fruit Dry Extract (1 g)
|
|
|
Coix Seed Oil Extract (2 x 1 g)
|
|
|
Colchicine (350 mg)
|
|
|
Colestipol Hydrochloride (200 mg)
|
|
|
Colistimethate Sodium (200 mg)
|
|
|
Colistin Sulfate (200 mg)
|
|
|
Collagenase I (2 x 0.5 mL) (COLD SHIPMENT REQUIRED)
|
|
|
Collagenase II (2 x 0.5 mL) (COLD SHIPMENT REQUIRED)
|
|
|
Color Related Compound 005 (20 mg) (3-hydroxy-2-naphthalenecarboxylic acid)
|
|
|
Color Related Compound 006 (20 mg) (3-hydroxy-4-[(4-methylphenyl)azo]-2-naphthalenecarboxylic acid)
|
|
|
Color Related Compound 007 (20 mg) (1-[(4-methylphenyl)azo]-2-naphthalenol)
|
|
|
Copovidone (100 mg)
|
|
|
Corosolic Acid (50 mg)
|
|
|
Cortisone (20 mg) (17, 21-Dihydroxypregna-4-ene-3,11,20-trione)
|
|
|
Cortisone Acetate (150 mg)
|
|
|
Cottonseed Oil (1 g)
|
|
|
Creatine (200 mg)
|
|
|
Creatinine (100 mg) (2-Imino-1-methylimidazolidin-4-one)
|
|
|
Cromolyn Sodium (500 mg)
|
|
|
Cromolyn Related Compound A (25 mg) (1,3-bis(2-acetyl-3-hydroxyphenoxy) propan-2-ol)
|
|
|
Cromolyn Related Compound B (25 mg) (Diethyl 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate))
|
|
|
Crospovidone (100 mg)
|
|
|
Crotamiton (200 mg)
|
|
|
Cumene (1.2 mL/ampule; 3 ampules)
|
|
|
Curcumin (30 mg)
|
|
|
Curcuminoids (300 mg)
|
|
|
Cyanidin Chloride (25 mg)
|
|
|
Cyanidin-3-O-glucoside Chloride (15 mg)
|
|
|
Cyanocobalamin (Crystalline) (2 x 150 mg)
|
|
|
Cyclamic Acid (100 mg)
|
|
|
シクランデレート
販売終了
|
|
|
Cyclic Olefin Polymer (250 mg)
|
|
|
Cyclizine Hydrochloride (200 mg)
|
|
|
Cyclizine Related Compound A (50 mg) (1-methylpiperazine)
|
|
|
Cyclobenzaprine Hydrochloride (200 mg)
|
|
|
Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol)
|
|
|
Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride)
|
|
|
Cyclohexylmethanol (1 mL/ampule; 2 ampules)
|
|
|
Cyclomethicone 4 (200 mg)
|
|
|
Cyclomethicone 5 (200 mg)
|
|
|
Cyclomethicone 6 (200 mg)
|
|
|
Cyclopentolate Hydrochloride (300 mg)
|
|
|
Cyclopentylpropanoic Acid (25 mg) (3-Cyclopentylpropanoic acid)
|
|
|
Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane)
|
|
|
Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate)
|
|
|
Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride)
|
|
|
Cycloserine (250 mg)
|
|
|
Cyclosporine (50 mg)
|
|
|
シクロチアジド (AS)
販売終了
|
|
|
Cyproheptadine Hydrochloride (500 mg)
|
|
|
Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene)
|
|
|
Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol)
|
|
|
Cyromazine (200 mg)
|
|
|
L-Cysteine Hydrochloride (600 mg)
|
|
|
Cystine (200 mg)
|
|
|
Cytarabine (250 mg)
|
|
|
5'-Cytidylic Acid (500 mg)
|
|
|
Cytosine (100 mg)
|
|
|
Conjugated Linoleic Acids - Free Fatty Acids (3 x 100 mg)
|
|
|
Calcium D,L-5-Methyltetrahydrofolate (300 mg)
|
|
|
Compressible Sugar (200 mg)
|
|
|
Citrus reticulata Pericarp Dry Extract (1 g)
|
|
|
Skim Milk Powder
販売終了
|
|
|
Skim Milk Powder with Melamine - Level A
販売終了
|
|
|
Skim Milk Powder with Melamine - Level C
販売終了
|
|
|
Skim Milk Powder with Melamine - Level D
販売終了
|
|
|
Skim Milk Powder with Melamine - Level E
販売終了
|
|
|
Saccharin (200 mg)
|
|
|
Saccharin Calcium (150 mg)
|
|
|
Saccharin Sodium (200 mg)
|
|
|
Safflower Oil (1 g)
|
|
|
Salicylamide (200 mg)
|
|
|
サリチル酸
|
|
|
Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid)
|
|
|
Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid)
|
|
|
Salidroside (25 mg) (2-(4-Hydroxyphenyl)ethyl-Beta-D-glucopyranoside)
|
|
|
Salmeterol Resolution Check (15 mg)
|
|
|
Salmeterol System Suitability (15 mg) (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
|
|
|
Salmeterol Xinafoate (150 mg)
|
|
|
Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol)
|
|
|
Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
|
|
|
Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
|
|
|
Salsalate (150 mg)
|
|
|
Salvianolic Acid B (25 mg)
|
|
|
Saquinavir Mesylate (200 mg)
|
|
|
Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide)
|
|
|
Schisandrin (15 mg)
|
|
|
Schisandra chinensis Fruit Dry Extract (1 g)
|
|
|
Scopolamine Hydrobromide (500 mg)
|
|
|
Scopoletin (20 mg)
|
|
|
Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid)
|
|
|
Selamectin (350 mg)
|
|
|
Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
|
|
|
Selenomethionine (100 mg)
|
|
|
Sennosides (500 mg)
|
|
|
Sennoside A (20 mg) ((9R,9'R)-5,5'-Bis(beta-d-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid)
|
|
|
Sennoside B (20 mg)
|
|
|
Sesame Oil (1 g)
|
|
|
Sesame Oil Related Compound A (12 mg/vial; 2 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL)
|
|
|
Sesame Oil Related Compound B (12 mg x 2 vials) ((1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol) (PLL))
|
|
|
L-Serine (200 mg)
|
|
|
Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
|
|
|
Sertraline Hydrochloride Related Compound A (25 mg) ((1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride)
|
|
|
Sertraline Hydrochloride (100 mg)
|
|
|
Sevoflurane (1 mL)
|
|
|
Sevoflurane Related Compound A (0.2 mL) (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether)
|
|
|
Sildenafil Citrate (100 mg)
|
|
|
Sevoflurane Related Compound B (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-methoxy-propane)
|
|
|
Sevoflurane Related Compound C (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-propanol)
|
|
|
Silver Sulfadiazine (200 mg)
|
|
|
Silybin (50 mg)
|
|
|
Silydianin (30 mg)
|
|
|
Simethicone (50 g)
|
|
|
Sildenafil Related Compound A (10 mg) (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
|
|
|
Simvastatin (200 mg)
|
|
|
Sisomicin Sulfate (500 mg)
|
|
|
Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
|
|
|
Sibutramine Related Compound B (20 mg) (N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
|
|
|
Sibutramine Related Compound C (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride)
|
|
|
Sibutramine Related Compound D (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride)
|
|
|
Sitagliptin Phosphate (200 mg)
|
|
|
Sitagliptin System Suitability Mixture (20 mg) (Sitagliptin Phosphate containing about 0.2% of S-enantiomer)
|
|
|
Sodium Acetate (1 g)
|
|
|
Sodium Acetate Trihydrate (1 g)
|
|
|
Sodium Ascorbate (200 mg)
|
|
|
Sodium Benzoate (1 g)
|
|
|
Sodium Bromide (1 g)
|
|
|
Sodium Butyrate (25 mg)
|
|
|
Sodium Bicarbonate (3 g)
|
|
|
Sodium Decanoyl Sarcosinate (30 mg) (Sodium N-decanoyl-N-methylglycinate)
|
|
|
Sodium Carbonate Anhydrous (1 g)
|
|
|
Sodium Chloride (1 g)
|
|
|
Sodium Citrate (1 g)
|
|
|
Sodium Cyclamate (200 mg)
|
|
|
Sodium D,L-Malate (50 mg) (PLANNED TO BE DISCONTINUED)
販売終了
|
|
|
Sodium D-Pantoate (100 mg)
|
|
|
Sodium Hyaluronate for IR Identification (250 mg)
|
|
|
Sodium Iron EDTA (200 mg)
|
|
|
Sodium Lactate (200 mg)
|
|
|
Sodium Lauryl Sulfate (1 g)
|
|
|
Sodium Myristoyl Sarcosinate (30 mg) (Sodium N-methyl-N-tetradecanoylglycinate)
|
|
|
Sodium Metabisulfite (2 X 500 mg)
|
|
|
モリブデン酸ナトリウム二水和物
販売終了
|
|
|
Sodium Nitrite (1 g)
|
|
|
Sodium Nitroprusside (500 mg)
|
|
|
Sodium Phenylbutyrate (200 mg)
|
|
|
Sodium Picosulfate (100 mg)
|
|
|
Sodium Picosulfate Related Compound A (20 mg) (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
|
|
|
Sodium Propionate (200 mg)
|
|
|
Sodium Salicylate (500 mg)
|
|
|
Sodium Starch Glycolate Type A (400 mg)
|
|
|
Sodium Starch Glycolate Type B (400 mg)
|
|
|
Sodium Stearyl Fumarate (200 mg)
|
|
|
Sodium Sulfate Anhydrous (1 g)
|
|
|
Sodium Tartrate Dihydrate (500 mg/vial; 4 vials)
|
|
|
Sodium Thiosulfate (1 g)
|
|
|
Sodium Trifluoroacetate (500 mg)
|
|
|
Solifenacin Succinate (100 mg)
|
|
|
Solifenacin Identification Mixture A (15 mg)
|
|
|
Sorbic Acid (1 g)
|
|
|
1,4-Sorbitan (300 mg)
|
|
|
Sorbitol (125 mg)
|
|
|
Sotalol Hydrochloride (300 mg)
|
|
|
Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride)
|
|
|
Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide)
|
|
|
Sotalol Related Compound C (50 mg) (N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride)
|
|
|
Soybean Oil (1 g)
|
|
|
Spectinomycin Hydrochloride (200 mg)
|
|
|
Spironolactone (125 mg)
|
|
|
Spironolactone Related Compound A (100 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione)
|
|
|
Spironolactone Related Compound B (30 mg) ((2'R)-7alpha-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
|
Spironolactone Related Compound C (30 mg) ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
|
Spironolactone Related Compound D (30 mg) ((2'R)-7alpha-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
|
|
|
Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture)
|
|
|
Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate)
|
|
|
Spirulina (2 x 100 mg)
|
|
|
Squalane (500 mg)
|
|
|
Stavudine (250 mg)
|
|
|
Stavudine System Suitability Mixture (10 mg)
|
|
|
Stearic Acid (500 mg)
|
|
|
Stearoyl Polyoxylglycerides (100 mg)
|
|
|
Stearyl Alcohol (125 mg)
|
|
|
Steviol Glycosides System Suitability (50 mg)
|
|
|
Stevioside (30 mg)
|
|
|
Streptomycin Sulfate (200 mg)
|
|
|
Succinic Acid (300 mg)
|
|
|
Succinylcholine Chloride (500 mg)
|
|
|
Succinylmonocholine Chloride (50 mg)
|
|
|
Sucrose Octaacetate (500 mg)
|
|
|
Sucralose (400 mg)
|
|
|
スクロース
販売終了
|
|
|
Sucromalt (200 mg)
|
|
|
Sulbactam (250 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Sulconazole Nitrate (200 mg)
|
|
|
Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate)
|
|
|
スルファベンズアミド
販売終了
|
|
|
Sulbactam Related Compound A (15 mg) ((2S)-2-Amino-3-methyl-3-sulfinobutanoic acid)
|
|
|
Sulbactam Related Compound D (15 mg) (Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate)
|
|
|
Sulbactam Related Compound E (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide)
|
|
|
Sulbactam Related Compound F (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid)
|
|
|
スルファセタミド
販売終了
|
|
|
Sulfacetamide Sodium (500 mg)
|
|
|
Sulfachlorpyridazine (200 mg)
|
|
|
Sulfadiazine (200 mg)
|
|
|
Sulfadimethoxine (200 mg)
|
|
|
Sulfadoxine (200 mg)
|
|
|
Sulfamerazine (500 mg)
|
|
|
Sulfamethazine (1 g)
|
|
|
Sulfamethazine Related Compound A (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate)
販売終了
|
|
|
Sulfamethazine Related Compound B (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide)
販売終了
|
|
|
Sulfamethizole (200 mg)
|
|
|
Sulfamethoxazole (200 mg)
|
|
|
Sulfamethoxazole N4-Glucoside (25 mg) (4-(beta-D-glucopyranosylamino)-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide)
|
|
|
Sulfamethoxazole Related Compound A (15 mg) (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide)
|
|
|
Sulfamethoxazole Related Compound B (15 mg) (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide)
|
|
|
Sulfamethoxazole Related Compound C (15 mg) (5-methylisoxazol-3-amine)
|
|
|
Sulfamethoxazole Related Compound F (15 mg) (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide)
|
|
|
Sulfanilamide (5 g)
|
|
|
Sulfanilamide Melting Point Standard (1 g) (Approximately 165 degrees)
|
|
|
Sulfanilic Acid (200 mg) (4-Aminobenzenesulfonic acid)
|
|
|
Sulfapyridine (200 mg)
|
|
|
Sulfaquinoxaline (200 mg)
|
|
|
Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide)
|
|
|
Sulfasalazine (125 mg)
|
|
|
Sulfathiazole (350 mg)
|
|
|
スルフィンピラゾン
販売終了
|
|
|
Sulfisoxazole (200 mg)
|
|
|
Sulfisoxazole Acetyl (200 mg)
|
|
|
Sulindac (200 mg)
|
|
|
Sulindac Related Compound A (20 mg) ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
|
Sulindac Related Compound B (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
|
Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)
|
|
|
Sulisobenzone (500 mg)
|
|
|
Sumatriptan (50 mg)
|
|
|
Sumatriptan Succinate (200 mg)
|
|
|
Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(Dimethylamino)ethyl]-2-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
|
|
|
Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
|
|
|
Sumatriptan Succinate Related Impurities (25 mg)
|
|
|
Sunflower Oil (1 g)
|
|
|
Suprofen (200 mg)
|
|
